Immunocore Holdings plc
IMCR
$28.38
-$1.67-5.54%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -20.48% | 864.24% | 31.73% | -25.64% | 40.64% |
| Total Depreciation and Amortization | 12.98% | -3.90% | -3.60% | 6.20% | 333.85% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -22.04% | -150.73% | -48.93% | -32.61% | -12.60% |
| Change in Net Operating Assets | 60.18% | 67.39% | 958.06% | -38.16% | -1,007.88% |
| Cash from Operations | 21.33% | 109.41% | 52,060.00% | -143.52% | -65.03% |
| Capital Expenditure | -338.68% | -290.57% | 76.27% | 85.67% | 29.32% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -333.29% | -290.57% | -25,013.33% | 85.67% | 59.74% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -91.21% | -98.09% | -97.43% | -6.27% | 108.48% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -923.65% | -98.09% | -107.07% | 6,350.76% | 2.49% |
| Foreign Exchange rate Adjustments | -220.86% | 251.48% | -104.69% | -135.91% | 124.71% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5,325.66% | 169.97% | -2,507.37% | 2,353.29% | 96.99% |
